Protective effects of erythropoietin against acute lung injury in a rat model of acute necrotizing pancreatitis

World Journal of Gastroenterology

Volumn 13, Issue 46, 2007, Pages 6172-6182

  Tascilar, Oge ^a   Cakmak, Güldeniz Karadeniz ^a   Tekin, Ishak Ozel ^a   Emre, Ali Ugur ^a   Ucan, Bulent Hamdi ^a   Bahadir, Burak ^a   Acikgoz, Serefden ^a   Irkorucu, Oktay ^a   Karakaya, Kemal ^a   Balbaloglu, Hakan ^a   Kertis, Gürkan ^a   Ankarali, Handan ^a   Comert, Mustafa ^a  

^a Faculty of Arts and Sciences   (Turkey)

Author keywords

Acute lung injury; Acute pancreatitis; Acute respiratory distress syndrome; Cytokine; Erythropoietin

Indexed keywords

AMYLASE; CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 6; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; RECOMBINANT ERYTHROPOIETIN; SODIUM CHLORIDE; TAURODEOXYCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE LUNG INJURY; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL PROTECTION; COMMON BILE DUCT; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LUNG PARENCHYMA; LUNG WEIGHT; MALE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PLEURA EFFUSION; RANDOMIZATION; RAT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; WISTAR RAT;

EID: 37849046733     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i46.6172     Document Type: Article

References (43)

1. Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004; 202: 145-156
2. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, Chevali L. Pathophysiology of acute pancreatitis. Pancreatology 2005; 5: 132-144
3. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9: 401-410
4. Pastor CM, Matthay MA, Frossard IL. Pancreatitis-associated acute lung injury: new insights. Chest 2003; 124: 2341-2351
5. Coleman T, Brines M. Science review: recombinant human erythropoietin in critical illness: a role beyond anemia? Crit Care 2004; 8: 337-341
6. Chong ZZ, Kang JQ, Maiese K. Angiogenesis and plasticity: role of erythropoietin in vascular systems. J Hematother Stem Cell Res 2002; 11: 863-871
7. Genc S, Koroglu TF, Genc K. Erythropoietin as a novel neuroprotectant. Res Neurol Neurosci 2004; 22: 105-119
8. Chong ZZ, Kang JQ, Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 2002; 106: 2973-2979
9. Chong ZZ, Kang JQ, Maiese K. Apaf-1, BcI-xL, cytochrome c, and caspase-9 form the critical elements for cerebral vascular protection by erythropoietin. J Cereb Blood Flow Metab 2003; 23: 320-330
10. Chong ZZ, Li F, Maiese K. Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. Histol Histopathol 2005; 20: 299-315
11. Ghezzi P, Brines M. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 2004; 11 Suppl 1: S37-S44
12. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA 2005; 293: 90-95
13. Kumral A, Uysal N, Tugyan K, Sonmez A, Yilmaz O, Gokmen N, Kiray M, Genc S, Duman N, Koroglu TF, Ozkan H, Genc K. Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia-ischemia in rats. Behav Brain Res 2004; 153: 77-86
14. Savino R, Ciliberto G. A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent. Cell Death Differ 2004; 11 [Suppl 1]: S2-S4
15. Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne AS. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003; 107: 294-299
16. Wu H, Ren B, Zhu J, Dong G, Xu B, Wang C, Zheng X, Jing H. Pretreatment with recombined human erythropoietin attenuates ischemia-reperfusion-induced lung injury in rats. Eur J Cardiothorac Surg 2006; 29: 902-907
17. Ozer EA, Kumral A, Ozer E, Yilmaz O, Duman N, Ozkal S, Koroglu T, Ozkan H. Effects of erythropoietin on hyperoxic lung injury in neonatal rats. Pediatr Res 2005; 58: 38-41
18. Yildirim E, Ozisik K, Solaroglu I, Kaptanoglu E, Beskonakli E, Sargon MF, Kilinc K, Sakinci U. Protective effect of erythropoietin on type II pneumocyte cells after traumatic brain injury in rats. J Trauma 2005; 58: 1252-1258
19. Yildirim E, Solaroglu L Okutan O, Ozisik K, Kaptanoglu E, Sargon MF, Sakinci U. Ultrastructural changes in tracheobronchial epithelia following experimental traumatic brain injury in rats: protective effect of erythropoietin. J Heart Lung Transplant 2004; 23: 1423-1429
20. Chen CC, Wang SS, Tsay SH, Lee FY, Lu RH, Chang FY, Lee SD. Effects of gabexate mesilate on serum inflammatory cytokines in rats with acute necrotizing pancreatitis. Cytokine 2006; 33: 95-99
21. Leme AS, Lichtenstein A, Arantes-Costa FM, Landucci EC, Martins MA. Acute lung injury in experimental pancreatitis in rats: pulmonary protective effects of crotapotin and N-acetyl-cysteine. Shock 2002; 18: 428-433
22. Lichtenstein A, Milani R Jr, Fernezlian SM, Leme AS, Capelozzi VL, Martins MA. Acute lung injury in two experimental models of acute pancreatitis: infusion of saline or sodium taurocholate into the pancreatic duct. Crit Care Med 2000; 28: 1497-1502
23. Udobi KF, Childs E, Touijer K. Acute respiratory distress syndrome. Am Fam Physician 2003; 67: 315-322
24. Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP, Slavin J. Inflammatory mediators in acute pancreatitis. J Pathol 2000; 190:117-125
25. Bhatia M. Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Curr Drug Targets Inflamm Allergy 2002; 1: 343-351
26. Puneet P, Moochhala S, Bhatia M. Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2005; 288: L3-L15
27. Chan YC, Leung PS. Acute pancreatitis: animal models and recent advances in basic research. Pancreas 2007; 34: 1-14
28. Milani Junior R, Pereira PM, Dolhnikoff M, Saldiva PH, Martins MA. Respiratory mechanics and lung morphometry in severe pancreatitis-associated acute lung injury in rats. Crit Care Med 1995; 23: 1882-1889
29. Granger J, Remick D. Acute pancreatitis: models, markers, and mediators. Shock 2005; 24 Suppl 1: 45-51
30. Takala A, Jousela I, Takkunen O, Kautiainen H, Jansson SE, Orpana A, Karonen SL, Repo H. A prospective study of inflamination markers in patients at risk of indirect acute lung injury. Shock 2002; 17: 252-257
31. Browne GW, Pitchumoni CS. Pathophysiology of pulmonary complications of acute pancreatitis. World J Gastroenterol 2006; 12: 7087-7096
32. Erbayraktar S, Grasso G, Sfacteria A, Xie QW, Coleman T, Kreilgaard M, Torup L, Sager T, Erbayraktar Z, Gokmen N, Yilmaz O, Ghezzi P, Villa P, Fratelli M, Casagrande S, Leist M, Helboe L, Gerwein J, Christensen S, Geist MA, Pedersen LO, Cerami-Hand C, Wuerth JP, Cerami A, Brines M. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci USA 2003; 100: 6741-6746
33. Bogoyevitch MA. An update on the cardiac effects of erythropoietin cardioprotection by erythropoietin and the lessons learnt from studies in neuroprotection. Cardiovasc Res 2004; 63: 208-216
34. Demols A, Van Laethem JL, Quertinmont E, Legros F, Louis H, Le Moine O, Deviere J. N-acetylcysteine decreases severity of acute pancreatitis in mice. Pancreas 2000; 20: 161-169
35. Esrefoglu M, Gul M, Ates B, Yilmaz I. Ultrastructural clues for the protective effect of ascorbic acid and N-acetylcysteine against oxidative damage on caerulein-induced pancreatitis. Pancreatology 2006; 6: 477-485
36. Bany-Mohammed FM, Slivka S, Hallman M. Recombinant human erythropoietin: possible role as an antioxidant in premature rabbits. Pediatr Res 1996; 40: 381-387
37. Kaptanoglu E, Solaroglu I, Okutan O, Surucu HS, Akbiyik F, Beskonakli E. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev 2004; 27: 113-120
38. Chong ZZ, Kang JO, Maiese K. Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 2002; 22: 503-514
39. Denham W, Yang J, Wang H, Botchkina G, Tracey KJ, Norman J. Inhibition of p38 mitogen activate kinase attenuates the severity of pancreatitis-induced adult respiratory distress syndrome. Crit Care Med 2000; 28: 2567-2572
40. Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA. Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 2002; 17: 463-467
41. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000; 47: 546-552
42. Maiese K, Li F, Chong ZZ. Erythropoietin in the brain: can the promise to protect be fulfilled? Trends Pharmacol Sci 2004; 25: 577-583
43. Jelkmann W, Wagner K. Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Ann Hematol 2004; 83: 673-686